October 2015 Archives

The nation's economy expanded less than expected in the third quarter to weigh the markets down to a lower close with the Dow dropping 92 points to 17,663. Nasdaq fell 20 points to 5,053.


On the upside


Bargain hunters snapped up shares of Exact Sciences (Nasdaq: EXAS).


AcelRx Pharmaceuticals (Nasdaq: ACRX) reported sharply higher third quarter earnings that beat expectations.


Imperva (NYSE: IMPV) narrowed third quarter losses more than expected and forecast current quarter results ahead of estimates.


On the downside


Valeant Pharmaceuticals (NYSE: VRX) severed ties with specialty pharmaceutical Philidor Rx Services but the stock price continued to plummet.


Fairway Group Holdings (Nasdaq: FWM) reported a greater than expected loss for the second quarter as revenue fell.


Calix (NYSE: CALX) reversed year ago losses to post a stronger than expected profit for the third quarter but the stock price fell. 

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while decliners edged out advancers by more than 7 to 5 on Nasdaq. The broader S&P 500 fell 10 points to 2,079. Bitcoin climbed $7 to $317. 

Markets rise as crude oil edges up

|

The markets turned positive during the midday with the Dow rising 16 points to 17,772 as crude oil prices edged up. Nasdaq added a point to 5,075.


On the upside


Fluidigm (Nasdaq: FLDM) narrowed third quarter losses more than expected.


Cray (Nasdaq: CRAY) reported higher third quarter earnings and revenue that surpassed analyst expectations.


A10 Networks (NYSE: ATEN) narrowed third quarter losses more than expected as revenue rose.


On the downside


Third quarter earnings for Control4 (Nasdaq: CTRL) tumbled as revenue fell short of expectations and the company forecast current quarter results below estimates.


Century Aluminum (Nasdaq: CENX) fell to a loss for the third quarter on lower revenue.


Ruckus Wireless (NYSE: RKUS) reported sharply lower third quarter earnings. 

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by 7 to 5 on Nasdaq. The broader S&P 500 eased a fraction to 2,088. Bitcoin gained $6 to $316. 

Mixed open as GDP falls short

|

The markets opened mixed with the Dow slipping 11 points to 17,744 while Nasdaq added a point to 5,075 as the nation's economy expanded less than expected in the third quarter.


On the upside


Third quarter earnings surged for Trimble Navigation (Nasdaq: TRMB) to surpass analyst expectations.


YRC Worldwide (Nasdaq: YRCW) reported sharply higher third quarter earnings that beat expectations.


VirtualScopics (Nasdaq: VSCP) narrowed third quarter losses as revenue rose.


On the downside


DigitalGlobe (NYSE: DGI) reported higher third quarter earnings but revenue fell short of expectations and the company forecast full year revenue below estimates.


Third quarter earnings for Aaron's (NYSE: AAN) fell short of expectations and the company lowered its full year earnings outlook.


SolarCity (Nasdaq: SCTY) widened third quarter losses more than expected. 

 

In the broad market, advancing issues outpaced decliners by a margin of more than 10 to 9 on the NYSE while decliners edged out advancers by 10 to 9 on Nasdaq. The broader S&P 500 lost 5 points to 2,084. Bitcoin gained $7 to $317. 

Disappointing economic data weighed the markets down to a lower close with the Dow slipping 23 points to 17,755. Nasdaq dropped 21 points to 5,074.


On the upside


Third quarter earnings for Iridium Communications (Nasdaq: IRDM) climbed to beat analyst expectations.


Quidel (Nasdaq: QDEL) narrowed losses for the third quarter as revenue rose.


HanesBrands (NYSE: HBI) reported higher third quarter earnings and revenue that surpassed estimates prompting the basic apparel company to lift its full year earnings outlook.


On the downside


Applied DNA Sciences (Nasdaq: APDN) responded to an anonymous opinion piece suggesting that investors short Applied DNA Sciences.


A Food and Drug Administration's advisory committee cancelled its meeting to review Repros Therapeutics' (Nasdaq: RPRX) New Drug Application for enclomiphene.


MiMedx Group (Nasdaq: MDXG) reported higher third quarter earnings and revenue but investors were disappointed that the results merely met expectations. 

 

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 eased a fraction to 2,089. Bitcoin slipped $1 to $308. 

The markets traded in negative territory during the midday with the Dow losing 31 points to 17,748 as first time applications for unemployment benefits rose. Nasdaq slipped 11 points to 5,083.


On the upside


Third quarter earnings surged for Rayonier Advanced Materials (NYSE: RYAM) to surpass expectations by a wide margin.


Echo Global Logistics (Nasdaq: ECHO) reported stronger than expected earnings for the third quarter.


One Horizon Group (Nasdaq: OHGI) announced that its Aishuo App has exceeded 10 million downloads.


On the downside


Second quarter earnings surged for Abiomed (Nasdaq: ABMD) but the stock price plunged.


Rovi (Nasdaq: ROVI) widened third quarter losses more than expected as revenue fell.


Buffalo Wild Wings (Nasdaq: BWLD) disappointed with lower third quarter earnings that missed expectations by a wide margin and lowered its full year forecast. 

 

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 slipped a point to 2,088. Bitcoin soared $15 to $314. 

A drop in pending homes sales weighed the markets down to a lower open with the Dow falling 64 points to 17,715. Nasdaq lost 19 points to 5,075.


On the upside


LifeLock (NYSE: LOCK) reported a smaller than expected loss for the third quarter and settled litigation with the Federal Trade Commission.


Exact Sciences (Nasdaq: EXAS) reported a loss for the third quarter but revenue from its Cologuard test has surged.


Revance Therapeutics (Nasdaq: RVNC) reported positive 6-month results from a Phase 2 study of injectable RT002.


On the downside


GNC Holdings (NYSE: GNC) disappointed with lower third quarter earnings that missed estimates and cut its full year outlook.


Third quarter earnings and revenue for GoPro (Nasdaq: GPRO) fell short of expectations prompting downgrades.


NXP Semiconductors (Nasdaq: NXPI) reported higher third quarter earnings and revenue but the company warned of weakening demand due to uncertain economic conditions. 

 

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 5 points to 2,085. Bitcoin climbed $10 to $310. 

Fed holds rates steady, market soar

|

The markets soared to close sharply higher with the Dow leaping 198 points to 17,779 as the Federal Reserve held interest rates steady. Nasdaq jumped 65 points to 5,095.


On the upside


Shares of Bank of America (NYSE: BAC) rose on expectations of an interest rate hike in December.


Apple (Nasdaq: AAPL) impressed with higher fourth quarter earnings and revenue that beat analyst expectations.


Boston Scientific (NYSE: BSX) reported a smaller than expected loss for the third quarter.


On the downside


Saia (Nasdaq: SAIA) disappointed with lower third quarter earnings that missed expectations by a wide margin.


Third quarter earnings dropped for Big 5 Sporting Goods (Nasdaq: BGFV) to fall short of expectations.


Shares of Intrepid Potash (NYSE: IPI) continued falling. 

 

In the broad market, advancing issues outpaced decliners by a margin of 7 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 surged 24 points to 2,090. Bitcoin rose $5 to $299. 

Markets soar as crude oil climbs

|

The markets extended its gains during the midday with the Dow soaring 111 points to 17,693 as crude oil prices climbed. Nasdaq gained 40 points to 5,070.


On the upside


U.S. Siica (NYSE: SLCA) reported sharply lower third quarter earnings and revenue but the stock price climbed.


Activist investor Elliott Associates acquired an 11% stake in Cabela (NYSE: CAB).


Bargain hunters lifted shares of Energy XXI (Nasdaq: EXXI).


On the downside


GenMark (Nasdaq: GNMK) widened losses for the third quarter.


Commercial Metals (NYSE: CMC) fell to a greater than expected loss for the fourth quarter.


Verisk Analytics (Nasdaq: VRSK) reported higher third quarter earnings but revenue missed expectations and the company announced plans to explore strategic alternatives for its healthcare data analytics business. 

 

In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The broader S&P 500 climbed 15 points to 2,081. Bitcoin added $4 to $299. 

Rebounding crude oil prices lifted the markets to a higher open with the Dow climbing 64 points to 17,645. Nasdaq rose 7 points to 5,037.


On the upside


Chicago Bridge & Iron (NYSE: CBI) will sell its nuclear constuction business to Westinghouse Electric.


Infinera (Nasdaq: INFN) reported higher third quarter earnings and revenue that topped analyst estimates.


Third quarter earnings and revenue climbed for CBRE Group (NYSE: CBG) to beat expectations.


On the downside


Third quarter earnings for Akamai Technologies (Nasdaq: AKAM) slipped and the company forecast current quarter earnings below estimates prompting a downgrade.


IDEXX Laboratories (Nasdaq: IDXX) reported lower third quarter earnings and forecast full year earnings that missed expectations.


Macrocure (Nasdaq: MCUR) reported disappointing results from a Phase 3 study of CureXcell(R) to treat diabetic foot ulcers. 

 

In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by 3 to 2 on Nasdaq. The broader S&P 500 gained 7 points to 2,073. Bitcoin rose $7 to $302. 

Crude oil drops, markets close lower

|

The markets closed lower with the Dow falling 41 points to 17,581 as crude oil prices dropped. Nasdaq slipped 4 points to 5,030.


On the upside


Pacira Pharmaceuticals (Nasdaq: PCRX) swung to a greater than expected profit for the third quarter as revenue rose.


Ctrip.com (Nasdaq: CTRP) will acquire a 445% stake in Qunar Cayman Islands (Nasdaq: QUNR) in a stock swap deal with Baidu (Nasdaq: BIDU).


Isis Pharmaceuticals (Nasdaq: ISIS) will host a webcast on Tuesday, November 3 to review ISIS-TTR data that was presented at the 1st European Congress of Hereditary ATTR Amyloidosis and provide a Phase 3 development plan update.


On the downside


Hi-Crush Partners (NYSE: HCLP) fell to a loss for the third quarter as revenue dropped and suspended its quarterly dividend.


Peabody Energy (NYSE: BTU) widened third quarter losses as revenue fell and warned that coal demand will continue to drop.


Knowles (NYSE: KN) widened losses for the third quarter. 

 

In the broad market, declining issues outpaced advancers by a margin of more than 3 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 lost 5 points to 2,065. Bitcoin gained $9 to $292. 

Losses extended at midday

|

The markets extended its losses during the midday with the Dow losing 60 points to 17,562. Nasdaq fell 15 points to 5,018.


On the upside


The Wall Street Journal reported that Walgreens (Nasdaq: WBA) was in advanced discussions to acquire Rite Aid (NYSE: RAD).


XOMA (Nasdaq: XOMA) initiated a Phase 2 proof-of-concept study for XOMA 358 in patients with congenital hyperinsulinism.


Agios Pharmaceuticals (Nasdaq: AGIO) will present data from a Phase 1 study of AG-120 in patients with IDH1-mutant positive advanced tumors at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics next week.


On the downside


Roadrunner Transportation (NYSE: RRTS) cut its third quarter guidance.


Endologix (Nasdaq: ELGX) reported a loss for the third quarter and announced plans to offer $150 million in convertible senior notes.


Intrepid Potash (NYSE: IPI) widened losses for the third quarter as sales plunged. 

 

In the broad market, declining issues outpaced advancers by a margin of nearly 4 to 1 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 dropped 10 points to 2,060. Bitcoin climbed $10 to $293. 

Plans by the government to sell millions of barrels of crude oil from its strategic reserves sent the markets down to a lower open with the Dow falling 58 points to 17,564. Nasdaq dropped 19 points to 5,014.


On the upside


Integrated Device Technology (Nasdaq: IDTI) reported higher second quarter earnings and revenue that topped analyst estimates and announced plans to acquire privately held ZMDI.


Amkor Technology (Nasdaq: AMKR) reported a better than expected profit for the third quarter.


Third quarter earnings for Huntsman (NYSE: HUN) beat analyst expectations.


On the downside


PricewaterhouseCoopers resigned as Marvell Technology Group's (Nasdaq: MRVL) external auditor.


Third quarter earnings for GrubHub (NYSE: GRUB) missed estimates and the restaurant delivery service forecast current quarter revenue below expectations.


Rent-A-Center (Nasdaq: RCII) fell to a loss for the third quarter and forecast current quarter as well as full year earnings below estimates. 

 

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 lost 9 points to 2,061. Bitcoin climbed $11 to $293. 

The markets closed mixed with the Dow losing 23 points to 17,623 even as investors expect the Federal Reserve to hold interest rates steady during its policy meeting beginning tomorrow. Nasdaq added 2 points to 5,034.


On the upside


LendingTree (Nasdaq: TREE) impressed with sharply higher third quarter earnings and revenue that surpassed analyst expectations.


Shares of Relypsa (Nasdaq: RLYP) continued climbing.


Macquarie upgraded Pandora Media (NYSE: P) from a Neutral rating to an Outperform rating.


On the downside


Arch Coal (NYSE: ACI) stock extended its losses.


Falling natural gas prices weighed down shares of EXCO Resources (NYSE: XCO).


Horsehead Holding (Nasdaq: ZINC) named Greg Belland to the position of senior vice president. 

 

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 3 points to 2,071. Bitcoin held steady at $283. 

Mixed markets at midday

|

The markets traded mixed during the midday with the Dow slipping 13 points to 17,632 while Nasdaq edged up a fraction to 5,032.


On the upside


Piedmont Natural Gas (NYSE: PNY) will be acquired by Duke Energy (NYSE: DUK) for a premium of approximately $4.9 billion in cash.


Eros International (NYSE: EROS) affirmed its strong business model.


Bargain hunters lifted shares of Merit Medical Systems (Nasdaq: MMSI).


On the downside


Xerox (NYSE: XRX) fell to a loss for the third quarter as revenue dropped and the company announced plans to review its business portfolio and capital allocation options.


Shares of Cemex (NYSE: CX) extended its losses.


Valeant Pharmaceuticals (NYSE: VRX) defended itself against allegations of questionable business practices but the stock price continued to fall. 

 

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 slipped 3 points to 2,071. Bitcoin eased a fraction to $282. 

Lower open ahead of Fed meeting

|

The markets opened lower with the Dow slipping 18 points to 17,628 ahead of the Federal Reserve's policy meeting. Nasdaq lost 6 points to 5,025.


On the upside


Ctrip.com International (Nasdaq: CTRP) swapped shares with Baidu (Nadaq: BIDU) to acquire a 45% stake in Qunar (Nasdaq: QUNR).


Bridgestone will pay a premium of approximately $835 million in cash to acquire Pep Boys (NYSE: PBY).


The Food and Drug Administration approved the chronic pain treatment BELBUCA which uses BioDelivery Sciences' (Nasdaq: BDSI) patented BioErodible MucoAdhesive drug delivery technology.


On the downside


Bank of America Merrill Lynch downgraded AK Steel (NYSE: AKS) from a Neutral rating to an Underperform rating and slashed its price target from $4.00 to $1.00.


Kinder Morgan (NYSE: KMI) extended its losses.


Investors locked in profits on Cirrus Logic (Nasdaq: CRUS). 

 

In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 lost 5 points to 2,069. Bitcoin held steady at $283. 

Lower interest rates in China along with strong tech sector earnings sent the markets soaring to a sharply higher close with the Dow jumping 157 points to 17,644. Nasdaq rocketed 111 points to 5,031.


On the upside


Second quarter earnings for QLogic (Nasdaq: QLGC) topped analyst estimates and the company forecast current quarter earnings ahead of expectations.


Bargain hunters lifted shares of Akorn (Nasdaq: AKRX).


Gigamon (NYSE: GIMO) swung to a better than expected profit for the third quarter as revenue climbed.


On the downside


Merit Medical Systems (Nasdaq: MMSI) disappointed with lower third quarter earnings that missed expectations.


Third quarter revenue for Huron Consulting Group (Nasdaq: HURN) fell short of expectations prompting the company to lower its full year revenue outlook.


Emerge Energy (NYSE: EMES) will not issue a cash dividend for the third quarter. 

 

In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 soared 22 points to 2,075. Bitcoin held steady at $273. 

Markets surge on strong earnings

|

Strong earnings boosted the markets during the midday with the Dow soaring 105 points to 17,594. Nasdaq leaped 97 points to 5,017.


On the upside


Netgear (Nasdaq: NTGR) reported third quarter earnings that surpassed analyst expectations by a wide margin.


Horizon Pharma (Nasdaq: HZNP) issued a statement denying allegations that it owned specialty pharmacies that sold its products and clarifying that the average prices of DUEXIS, VIMOVO, PENNSAID and RAYOS have not increased over the past year.


athenahealth (Nasdaq: ATHN) reversed year ago losses to post a greater than expected profit for the third quarter as revenue climbed.


On the downside


Ocular Therapeutix (Nasdaq: OCUL) reported that OTX-TP reduced intraocular pressure in a Phase 2b clinical trial but the study did not detect statistically significant differences between patient groups.


Westmoreland Coal (Nasdaq: WLB) reported a loss for the third quarter and lowered its full year forecast.


Stericycle (Nasdaq: SRCL) disappointed with sharply lower third quarter earnings that fell short of expectations. 

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 gained 16 points to 2,069. Bitcoin added $2 to $274. 

China's central bank lowered interest rates to send the markets soaring with the Dow surging 108 points to 17,598. Nasdaq jumped 92 points to 5,012.


On the upside


Microsoft (Nasdaq: MSFT) reported higher first quarter earnings that topped analyst estimates.


Amazon (Nasdaq: AMZN) reversed year ago losses to post an unexpected profit for the third quarter as revenue surged.


Google parent Alphabet (Nasdaq: GOOG) reported higher third quarter earnings and revenue that beat expectations.


On the downside


Pandora Media (NYSE: P) widened third quarter losses more than expected prompting downgrades.


Skechers (NYSE: SKX) disappointed with third quarter earnings and revenue that fell short of analyst expectations.


Fortinet (Nasdaq: FTNT) reported higher third quarter earnings and revenue but investors were disappointed that the company forecast current quarter results that merely met expectations. 

 

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 climbed 18 points to 2,070. Bitcoin added $3 to $274. 

Investors cheered the European Central Bank's decision to hold interest rates steady at historic lows. The Dow zoomed 320 points to 17,489. Nasdaq jumped 79 points to 4,920.


On the upside


Trinity Biotech (Nasdaq: TRIB) reported higher third quarter earnings.


Boise Cascade (NYSE: BCC) reported third quarter earnings and revenue that beat expectations.


Credit Suisse upgraded Energy Recovery (Nasdaq: ERII) from a Neutral rating to an Outperform rating.


On the downside


The Food and Drug Administration warned that patients using AbbVie's (NYSE: ABBV) hepatitis C treatments Viekira Pak and Technivie are at a higher risk of serious liver injury.


Shares of Encanta Pharmaceuticals (Nasdaq: ENTA), which helped develop some of AbbVie's treatments, plunged on the FDA warning.


Cabela (NYSE: CAB) disappointed with lower third quarter earnings that fell short of expectations. 

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 surged 33 points to 2,052. Bitcoin added $5 to $270. 

First time applications for unemployment benefits rose less than expected to boost the markets higher during the midday with the Dow rocketing 273 points to 17,442. Nasdaq leaped 60 points to 4,901.


On the upside


Third quarter revenue rose for TrueBlue (NYSE: TBI) to surpass expectations and the company forecast fourth quarter results above estimates.


Sequans Communications (NYSE: SQNS) narrowed third quarter losses more than expected as revenue rose.


CIT Group (NYSE: CIT) announced plans to explore strategic options for its $10 billion Commercial Air business, will sell its CIT Canada and CIT China businesses, and said that chief executive John A. Thain will retire on March 31, 2016.


On the downside


Apollo Education Group (Nasdaq: APOL) fell to a greater than expected loss for the fourth quarter and forecast 2016 revenue below estimates.


The Food and Drug Administration approved Relypsa's (Nasdaq: RLYP) Veltassa to treat hyperkalemia but the requirement for a box warning that Veltassa could potentially interfere with other drugs sent the stock price tumbling.


Mizuho Securities downgraded Tenet Healthcare (NYSE: THC) from an Outperform rating to a Neutral rating. 

 

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 soared 29 points to 2,048. Bitcoin added $5 to $270. 

The European Central Bank maintained interest rates at historic lows sending the markets soaring to a sharply higher open with the Dow leaping 214 points to 17,382. Nasdaq jumped 67 points to 4,907.

On the upside

eBay (Nasdaq: EBAY) reported higher third quarter earnings that topped analyst estimates.

Oclaro (Nasdaq: OCLR) reported preliminary first quarter revenue above its previous guidance.

Texas Instruments (Nasdaq: TXN) reported better than expected third quarter earnings and revenue.

On the downside

Community Health Systems (NYSE: CYH) warned that third quarter earnings and revenue would fall short of expectations.

Envision Healthcare (NYSE: EVHC) disappointed with sharply lower third quarter earnings that missed expectations and cut its full year earnings outlook.

BMO Capital Markets Valeant Pharmaceuticals (NYSE: VRX) from an Outperform rating to a Market Perform rating.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 soared 21 points to 2,040. Bitcoin gained $5 to $271.
Falling crude oil prices sent the markets down to a lower close with the Dow falling 48 points to 17,168. Nasdaq tumbled 40 points to 4,840.

On the upside

Angie's List (Nasdaq: ANGI) swung to a better than expected profit for the third quarter as revenue rose.

Woodford Investment Management will invest $30 million in Northwest Biotherapeutics (Nasdaq: NWBO).

Great Places to Work Institute ranked Cirrus Logic (Nasdaq: CRUS) 8th on its 2015 Best Small and Medium Workplaces in the nation.

On the downside

Concordia Healthcare (Nasdaq: CXRX) completed its acquisition of Amdipharm Mercury.

Endo International (Nasdaq: ENDP) clarified that less than 10% of its revenue came from specialty pharmacies and that those specialty pharmacies were independent of Endo but the stock price plunged.

Investors speculated that Vivint Solar (NYSE: VSLR) will reject SunEdison's (NYSE: SUNE) proposed acquisition.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 tumbled 11 points to 2,018. Bitcoin held steady at $266.

Markets advance on upbeat earnings

|
Upbeat earnings lifted the markets during the midday with the Dow climbing 90 points to 17,307. Nasdaq added a point to 4,882.

On the upside

Tupperware Brands (NYSE: TUP) reported higher third quarter earnings that surpassed analyst expectations.

Third quarter earnings and revenue rose for Zix (Nasdaq: ZIXI) to top expectations.

Brean Capital analyst Anne Shih upgraded New Oriental Education & Technology Group (NYSE: EDU) from a Hold rating to a Buy rating.

On the downside

Citron Research alleged that Valeant Pharmaceuticals (NYSE: VRX) falsified sales through a network of phantom pharmacies.

Pearson (NYSE: PSO) cut its full year forecast.

Celestica (NYSE: CLS) disappointed with lower third quarter earnings and revenue that fell short of expectations.
 
In the broad market, advancing issues were on par with decliners on the NYSE while decliners outpaced advancers by 9 to 7 on Nasdaq. The broader S&P 500 added 2 points to 2,033. Bitcoin held steady at $266.
The markets opened lower with the Dow slipping 2 points to 17,214 as crude oil prices continued to fall. Nasdaq dropped 22 points to 4,858.

On the upside

KLA-Tencor (Nasdaq: KLAC) will be acquired by Lam Research (Nasdaq: LRCX) in a cash and stock deal value at approximately $10.6 billion.

Silver Lake Partners and Thoma Bravo will take SolarWinds (NYSE: SWI) private for a premium of approximately $4.5 billion.

Neogenomics (Nasdaq: NEO) will acquire Clarient in a cash and stock deal valued at approximately $275 million.

On the downside

Synta Pharmaceuticals (Nasdaq: SNTA) terminated its Phase 3 GALAXY-2 trial of ganetespib and docetaxel to treat advanced lung cancer.

Raymond James downgraded VMware (NYSE: VMW) from an Outperform rating to a Market Perform rating while Sterne Agee downgraded the company from a Buy rating to a Neutral rating and Pacific Crest downgraded the company from an Overweight rating to a Sector Weight rating.

Polaris Industries (NYSE: PII) reported higher third quarter earnings and revenue that topped analyst estimates but the stock price fell.
 
In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 lost 4 points to 2,026. Bitcoin slipped $1 to $265.

Markets slip as crude oil retreats

|
Crude oil prices slipped to send the markets down to a modestly lower close with the Dow falling 13 points to 17,217. Nasdaq lost 24 points to 4,880.

On the upside

Higher One Holdings (NYSE: ONE) will sell its Campus Labs data analytics business to an affiliate of Leeds Equity Partners for approximately $91 million in cash.

EXCO Resources (NYSE: XCO) entered agreements to reduce debt and amended its credit agreement.

Rising gold prices lifted shares of Yamana Gold (NYSE: AUY).

On the downside

Investors continued to lock in profits on Eros International (NYSE: EROS).

Exar (NYSE: EXAR) announced the departure of president and chief executive Louis DiNardo and reported preliminary second quarter earnings and revenue that fell short of expectations.

Motorola Solutions (NYSE: MSI) introduced a new body camera with radio speaker and microphone which sent shares of TASER International (Nasdaq: TASR) tumbling.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE while decliners barely edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 2,030. Bitcoin rose $4 to $266.

Markets lower as oil retreats

|
The markets traded lower during the midday with the Dow slipping 26 points to 17,204 as crude oil prices retreated. Nasdaq fell 32 points to 4,873.

On the upside

Third quarter earnings for Helix Energy (NYSE: HLX) topped analyst estimates.

Team Health (NYSE: TMH) rejected an unsolicited acquisition offer from AmSurg (Nasdaq: AMSG).

Tile Shop Holdings (Nasdaq: TTS) impressed with sharply higher third quarter earnings and revenue that beat expectations and forecast full year revenue ahead of estimates.

On the downside

A New York Times article revealed that Horizon Pharma (Nasdaq: HZNP) charges $1,500 per month for Duexis which costs approximately $60 per month.

Redstone Technology Research downgraded Micron Technology (Nasdaq: MU) from a Neutral rating to a Short rating and slashed its price target from $20 to $13.

Allegheny Technologies (NYSE: ATI) reported a loss for the third quarter as revenue dropped.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 lost 4 points to 2,028. Bitcoin rose $5 to $267.

Lower open as earnings disappoint

|
Disappointing earnings weighed the markets down to a lower open with the Dow losing 40 points to 17,189. Nasdaq slipped 3 points to 4,902.

On the upside

Energy Recovery (Nasdaq: ERII) signed a 15-year license to provide Schlumberger (NYSE: SLB) with exclusive rights to Energy Recovery's VorTeq(TM) hydraulic pumping system.

Barclays upgraded Weight Watchers (NYSE: WTW) from an Underweight rating to an Equal Weight rating.

The Food and Drug Administration granted Fast Track and Orphan Drug designation to Corbus Pharmaceuticals' (Nasdaq: CRBP) cystic fibrosis treatment Resunab.

On the downside

Harley-Davidson (NYSE: HOG) reported lower third quarter earnings that fell short of analyst expectations, lowered its shipment forecast and announced job cuts.

Rambus (Nasdaq: RMBS) reported third quarter earnings and revenue that missed estimates.

Progressive Waste Solutions (NYSE: BIN) reported preliminary third quarter revenue below expectations.
 
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by 5 to 3 on Nasdaq. The broader S&P 500 slipped 2 points to 2,031. Bitcoin added $3 to $266.

Higher close on M&A activity

|
The markets closed modestly higher with the Dow rising 14 points to 17,230 despite a drop in crude oil prices as investors focused on merger and acquisition activity. Nasdaq gained 18 points to 4,905.

On the upside

Dehaier Medical Systems (Nasdaq: DHRM) will distribute its C-arm X-Ray machine and defibrillator monitor to Dongshen Hospital of Ordos, Inner Mongolia.

Adaptimmune Therapeutics (Nasdaq: ADAP) chief operating officer Helen Tayton-Martin will present at the 2015 BIO Investor Forum tomorrow, October 20.

Shares of Turtle Beach (Nasdaq: HEAR) continued climbing.

On the downside

A group of Arch Coal (NYSE: ACI) lenders succeeded in blocking a debt-swap deal.

Falling crude oil prices weighed down shares of Baytex Energy (NYSE: BTE).

JP Morgan downgraded Carpenter Technology (NYSE: CRS) from an Overweight rating to a Neutral rating.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 held steady at 2,033. Bitcoin added $2 to $262. 

Markets slip as growth slows in China

|
Slowing growth in China weighed the markets down during the midday with the Dow slipping 24 points to 17,191. Nasdaq lost 8 points to 4,878.

On the upside

Shares of Keryx Biopharmaceuticals (Nasdaq: KERX) extended its gains.

Northwest Biotherapeutics (Nasdaq: NWBO) issued a statement saying that it was unaware of any reason for the sharp drop in its stock price on Friday.

Bargain hunters lifted shares of Zafgen (Nasdaq: ZFGN).

On the downside

Great Lakes Dredge & Dock (Nasdaq: GLDD) withdrew its full year earnings outlook and initiated a review of strategic alternatives to increase shareholder value.

Investors locked in profits on PTC Therapeutics (Nasdaq: PTCT).

A beta-thalassemia patient treated with the first generation version of Bluebird Bio's (Nasdaq: BLUE) gene therapy suffered a relapse.
 
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE while advancers edged out decliners by more than 5 to 4 on Nasdaq. The broader S&P 500 lost 2 points to 2,030. Bitcoin added $2 to $262.

Mixed open as oil prices fall

|
The markets opened mixed with the Dow losing 31 points to 17,184 while Nasdaq added 5 points to 4,892 as investors welcomed corporate consolidations but monitored falling crude oil prices.

On the upside

Oprah Winfrey acquired a 10% stake in Weight Watchers International (NYSE: WTW) for approximately $43.2 million.

Microsemi (Nasdaq: MSCC) offered a premium of approximately $2.2 billion in cash and stock to acquire PMC-Sierra (Nasdaq: PMCS) topping a $2 billion bid by Skyworks Solutions (Nasdaq: SWKS).

Campus Crest Communities (NYSE: CCG) will be acquired by Harrison Street Real Estate Capital in deal valued at approximately $1.9 billion.

On the downside

Morgan Stanley (NYSE: MS) disappointed with sharply lower that fell far short of analyst expectations.

Genocea Biosciences (Nasdaq: GNCA) reported disappointing results from a Phase 2a clinical trial of its pneumococcus vaccine GEN-004.

Third quarter earnings for Valeant Pharmaceuticals (NYSE: VRX) tumbled.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 fell 9 points to 2,023. Bitcoin added $2 to $262.

Higher close on strong earnings

|
Upbeat corporate earnings lifted the markets to a higher close with the Dow gaining 74 points to 17,215. Nasdaq climbed 16 points to 4,886.

On the upside

Rockwell Medical (Nasdaq: RMTI) introduced its new Triferic mode-of-action video that shows how Triferic replaces iron that is lost by hemodialysis patients.

Shares of Five Prime Therapeutics (Nasdaq: FPRX) extended its gains.

Former Microsoft (Nasdaq: MSFT) chief executive Steve Ballmer acquired a 4% stake in Twitter (NYSE: TWTR).

On the downside

Shares of NorthwestBiotherapeutics (Nasdaq: NWBO) continued falling.

Goldman Sachs downgraded Universal Display (Nasdaq: OLED) from a Buy rating to a Neutral rating.

Kansas City Southern (NYSE: KSU) disappointed with lower third quarter earnings and revenue that fell short of expectations.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 gained 9 points to 2,033. Bitcoin rose $5 to $259.

Markets advance at midday

|
The markets advanced during the midday with the Dow rising 36 points to 17,178 as crude oil prices advanced. Nasdaq gained 7 points to 4,877.

On the upside

SFX Entertainment (Nasdaq: SFXE) founder and chief executive officer Robert Sillerman offered to take the company private.

Shares of Weibo (Nasdaq: WB) climbed on news that Alibaba (NYSE: BABA) offered to acquire Youku Tudou (NYSE: YOKU).

Bargain hunters lifted shares of Keryx Biopharmaceuticals (Nasdaq: KERX).

On the downside

WaferGen Bio-systems (Nasdaq: WGBS) priced its public offering of 3.92 million common shares at the discounted price of $1 per share.

Morgan Stanley downgraded Spirit Airlines (Nasdaq: SAVE) from an Overweight rating to an Equal Weight rating and slashed its price target from $66 to $53.

Genworth Financial (NYSE: GNW) chief financial officer Martin Klein resigned.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 added 4 points to 2,027. Bitcoin gained $8 to $262.

Crude oil rises, markets open higher

|
The markets opened higher with the Dow gaining 30 points to 17,172 as crude oil prices advanced. Nasdaq rose 5 points to 4,875.

On the upside

Alibaba (NYSE: BABA) offered a premium of approximately $3.6 billion in cash to purchase Youku Tudou (NYSE: YOKU).

Third quarter earnings for General Electric (NYSE: GE) topped expectations.

Mattel (Nasdaq: MAT) reported lower third quarter earnings and revenue that fell short of estimates but the stock price rose.

On the downside

Cempra (Nasdaq: CEMP) reported positive data from a Phase 3 clinical trial of intravenous to oral solithromycin to treat patients with community-acquired bacterial pneumonia but the stock price fell.

Quanta Services (NYSE: PWR) lowered its third quarter earnings and revenue outlook.

The Food and Drug Administration placed a partial hold on the development of Zafgen's (Nasdaq: ZFGN) obesity treatment beloranib after a patient in a late stage study died.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 gained 6 points to 2,030. Bitcoin rose $6 to $260.
Upbeat earnings along with a drop in jobless claims sent the markets soaring to a sharply higher close with the Dow rocketing 217 points to 17,141. Nasdaq leaped 87 points to 4,870.

On the upside

An existing shareholder of Affimed (Nasdaq: AFMD) increased its holdings by 3.3 million common shares.

Dyax (Nasdaq: DYAX) was added to the NYSE Arca Biotechnology Index.

Bloomberg reported that Staples (Nasdaq: SPLS) will sell assets in order to win approval of its proposed acquisition of Office Depot (Nasdaq: ODP).

On the downside

Netflix (Nasdaq: NFLX) reported lower third quarter earnings as the company added fewer U.S. streaming customers than expected.

Koppers Holdings (NYSE: KOP) will release third quarter earnings before market open on Thursday, November 5.

Shares of Renewable Energy Group (Nasdaq: REGI) extended its losses.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 leaped 29 points to 2,023. Bitcoin added $2 to $254.
The markets advanced during the midday with the Dow climbing 89 points to 17,014 as jobless claims fell to its lowest level in four decades. Nasdaq gained 33 points to 4,816.

On the upside

Dexcom (Nasdaq: DXCM) reported preliminary third quarter revenue above analyst estimates.

Shares of Radius Health (Nasdaq: RDUS) extended its gains.

BofI Holding (Nasdaq: BOFI) denied allegations of wrongdoing and addressed complaints raised in a lawsuit against the company.

On the downside

Imprivata (NYSE: IMPR) reported preliminary third quarter earnings and revenue below analyst expectations.

Preliminary third quarter revenue for Garmin (Nasdaq: GRMN) fell short of expectations prompting the company to lower its full year forecast.

Third quarter earnings and revenue fell for Marriott Vacations (NYSE: VAC).
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 climbed 11 points to 2,005. Bitcoin added $3 to $255.

Higher open as jobless claims drop

|
First time applications for unemployment benefits dropped to its lowest level in nearly 42 years to lift the markets to a higher open with the Dow gaining 41 points to 16,966. Nasdaq climbed 30 points to 4,813.

On the upside

Five Prime Therapeutics (Nasdaq: FPRX) entered an exclusive license agreement for Bristol-Myers Squibb (NYSE: BMY) to develop and commercialize Five Prime's CSF1R antibody program.

Transition Therapeutics (Nasdaq: TTHI) reported that Alzheimer's disease patients with severe agitation and aggression benefited from ELND005 in a Phase 2/3 study.

Sales of Tata Motors' (NYSE: TTM) Jaguar Land Rover climbed in September.

On the downside

Seagate Technology (Nasdaq: STX) trimmed its first quarter revenue outlook.

Manitowoc (NYSE: MTW) warned of sharply lower third quarter earnings.

HCA Holdings (NYSE: HCA) reported lower preliminary third quarter earnings and revenue.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by 5 to 2 on Nasdaq. The broader S&P 500 gained 7 points to 2,001. Bitcoin added $2 to $254. 

Markets plunge over retailer woes

|
The markets tumbled to a sharply lower close with the Dow plummeting 157 points to 16,980 after Wal-Mart warned of lower earnings for the next fiscal year. Nasdaq lost 13 points to 4,782.

On the upside

RBC Capital Markets lifted its price target on Intel (Nasdaq: INTC) from $33 to $34.

Bloomberg reported that Micron Technology (Nasdaq: MU) initiated conversations with SanDisk (Nasdaq: SNDK) for a possible acquisition.

Rising gold prices lifted shares of Barrick Gold (NYSE: ABX).

On the downside

Amyris (Nasdaq: AMRS) will offer $50 million in convertible senior notes.

Shares of Eros International (NYSE: EROS) continued falling after announcing yesterday that it acquired music messaging company PingTune.

The Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee will not review Sarepta Therapeutics' (Nasdaq: SRPT) New Drug Application for the Duchenne muscular dystrophy treatment eteplirsen until January 22, 2016.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 3 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 lsot 9 points to 1,994. Bitcoin added $4 to $252.
Disappointing earnings weighed the markets down during the midday with the Dow plunging 101 points to 16,980. Nasdaq rose 10 points to 4,807.

On the upside

Bloomberg reported that Fairchild Semiconductor International (Nasdaq: FCS) retained the services of Goldman Sachs to sell the company.

Zafgen (Nasdaq: ZFGN) disclosed that a patient in an ongoing Phase 3 study of its Prader-Willi Syndrome treatment beloranib died. The stock price rose after two days of uncertainty when the company cancelled investor meetings.

Rising gold prices lifted shares of Kinross Gold (NYSE: KGC) .

On the downside

The New York Times reported that one of BofI Holding's (Nasdaq: BOFI) former auditors sued the company for violating federal whistle-blower laws.

Blucora (Nasdaq: BCOR) will buy HD Vest Financial Services for approximately $580 million.

Austin Ventures will distribute its holdings in Bazaarvoice (Nasdaq: BV).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 2 points to 2,000. Bitcoin added $5 to $253.

Higher open as retail sales edge up

|
September retail sales edged up to lift the markets to a higher open with the Dow rising 12 points to 17,094. Nasdaq gained 16 points to 4,812.

On the upside

TripAdvisor (Nasdaq: TRIP) partnered with Priceline Group (Nasdaq: PCLN) to list Priceline's available accommodations on TripAdvisor's online booking platform.

Bloomberg reported that SanDisk (Nasdaq: SNDK) was exploring a possible sale of the company.

CASI Pharmaceuticals (Nasdaq: CASI) received orphan drug designation from the European Medicines Agency for ENMD-2076 to treat hepatocellular carcinoma.

On the downside

Cepheid (Nasdaq: CPHD) warned that third quarter results would fall short of expectations and forecast current quarter revenue below estimates.

Shares of Sarepta Therapeutics (Nasdaq: SRPT) continued falling.

Colfax (NYSE: CFX) disappointed with sharply lower third quarter earnings that fell short of analyst expectations.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 added 3 points to 2,007. Bitcoin rose $2 to $249.
Retreating crude oil prices weighed the markets down to a lower close with the Dow losing 49 points to 17,081. Nasdaq tumbled 42 points to 4,796.

On the upside

Fortress Investment Group (NYSE: FIG) will close the Fortress Macro Fund after disappointing performance this year.

Shares of Genocea Biosciences (Nasdaq: GNCA) extended its gains.

Deerfield Management acquired a 9.97% stake in XenoPort (Nasdaq: XNPT).

On the downside

Investors locked in profits on Heron Therapeutics (Nasdaq: HRTX).

MiMedx Group (Nasdaq: MDXG) reported sharply higher third quarter revenue but the stock price fell after the company established a credit facility.

Intrexon (NYSE: XON) subsidiary ViaGen Pets successfully delivered two litters of healthy, cloned kittens for clients but the stock price plunged.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 dropped 13 points to 2,003. Bitcoin rose $3 to $247.

Markets rise at midday

|
The markets traded higher during the midday with the Dow rising 15 points to 17,147 as investors monitored earnings. Nasdaq added 2 points to 4,841.

On the upside

Yadkin (Nasdaq: YDKN) will acquire NewBridge (Nasdaq: NBBC) in an all stock transaction valued at approximately $456 million.

Lattice Semiconductor (Nasdaq: LSCC) will host its third quarter financial results conference call on Thursday, October 29.

Twitter (NYSE: TWTR) will eliminate approximately 8% of its employees.

On the downside

Bloomberg reported that Zafgen (Nasdaq: ZFGN) cancelled a roadshow that was scheduled for today and an investor dinner tomorrow night.

SunCoke Energy (NYSE: SXC) extended its losses.

SkyWest (Nasdaq: SKYW) reported a drop in September block hours.
 
In the broad market, declining issues outpaced advancers by a margin of 10 to 9 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 held steady at 2,017. Bitcoin rose $3 to $247.

Higher open as oil prices rise

|
Crude oil prices edged up to lift the markets to a modestly higher open with the Dow adding 5 points to 17,137. Nasdaq rose 6 points to 4,845.

On the upside

Wausau Paper (NYSE: WPP) will be acquired by SCA for a premium of approximately $513 million in cash.

China Jo-Jo Drugstores (Nasdaq: CJJD) reported that online pharmacy sales surged 438% in the first half of the year.

Bloomberg reported that Molson Coors Brewing (NYSE: TAP) will have the right of first and last offer to purchase SABMiller's 58% interest in their joint venture MillerCoors.

On the downside

HeartWare International (Nasdaq: HTWR) will not re-initiate enrollment in a halted MVAD clinical trial in November as previously expected.

Ryder System (NYSE: R) cut its third quarter and full year earnings outlook and forecast fourth quarter earnings below expectations.

JPMorgan downgraded JetBlue Airways (Nasdaq: JBLU) from an Overweight rating to a Neutral rating.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 held steady at 2,017. Bitcoin rose $3 to $247.
The markets closed higher with the Dow climbing 47 points to 17,131 even as crude oil prices fell. Nasdaq rose 8 points to 4,838.

On the upside

Alibaba Group (NYSE: BABA) will host a launch ceremony for the 11.11 Global Shopping Festival.

Facebook (Nasdaq: FB) introduced new ad features that allow users to make purchases without leaving Facebook.

SuperLobby reported that Yahoo's (Nasdaq: YHOO) daily fantasy sports platform collected more in entry fees than it paid in prizes.

On the downside

2U (Nasdaq: TWOU) will release third quarter earnings after market close on November 5.
 
Profit taking continued to weigh down shares of Unit (NYSE: UNT).

Shares of Petrobras (NYSE: PBR) fell as crude oil prices dropped.
 
In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on the NYSE while declines edged out advancers by 10 to 9 on Nasdaq. The broader S&P 500 added 2 points to 2,017. Bitcoin lost $2 to $244. 

Markets higher at midday

|
The markets traded higher during the midday with the Dow gaining 34 points to 17,119. Nasdaq added 2 points to 4,833.

On the upside

Insider Monkey reported that hedge funds have increased their holdings in Lattice Semiconductor (Nasdaq: LSCC).

Shares of MeetMe (Nasdaq: MEET) continued rising.

Heron Therapeutics (Nasdaq: HRTX) named Neil J. Clendeninn, M.D., Ph.D. to the position of chief medical officer.

On the downside

Profit taking continued to weigh down shares of Stone Energy (NYSE: SGY).
 
Insider Monkey noted that fewer hedge funds reported holdings in Bonanza Creek Energy (NYSE: BCEI).

Re/Code reported that Twitter (NYSE: TWTR) had plans to layoff engineers.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while declines edged out advancers by 10 to 9 on Nasdaq. The broader S&P 500 held steady at 2,015. Bitcoin lost $1 to $244.

Flat open ahead of earnings

|
The markets opened flat with the Dow rising 4 points to 17,088 while Nasdaq slipped 7 points to 4,823 as investors awaited earnings reports.

On the upside

Celsion (Nasdaq: CLSN) reported upbeat preclinical data for its GEN-1 IL-12 in combination with Avastin and Doxil to treat ovarian cancer.

Shares of Esperion Therapeutics (Nasdaq: ESPR) rose after Eli Lilly (NYSE: LLY) discontinued development of its heart disease treatment.

Shares of Xenoport (Nasdaq: XNPT) continued to rise.

On the downside

Sientra (Nasdaq: SIEN) recommended that plastic surgeons temporarily discontinue implanting devices manufactured by Silimed and has temporarily discontinued the sale of Silimed devices.
 
Shares of VMware (NYSE: VMW), which is 80% owned by EMC (NYSE: EMC), fell on news that Dell offered to purchase EMC in a deal valued at approximately $67 billion.

SunCoke Energy (NYSE: SXC) reported lower third quarter earnings and revenue.
 
In the broad market, declining issues outpaced advancers by a margin of 7 to 5 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 2 points to 2,012. Bitcoin lost $1 to $244.

Higher close as commodities climb

|
Rising commodities prices lifted the markets to a modestly higher close with the Dow gaining 33 points to 17,084. Nasdaq climbed 19 points to 4,830.

On the upside

American Airlines (NYSE: AAL) reported a strong 7.2% increase in September total revenue passenger miles.

International Paper (NYSE: IP) will sell its 55% stake in joint venture Shandong Sun Holding Group.

Bargain hunters lifted shares of Yum Brands (NYSE: YUM).

On the downside

Third quarter earnings for Alcoa (NYSE: AA) fell short of analyst expectations as revenue dropped.
 
Investors locked in profits on Frontier Communications (Nasdaq: FTR).

Profit taking weighed down shares of Genworth Financial (NYSE: GNW).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 added a point to 2,014. Bitcoin added $1 to $243.
The markets traded mixed during the midday with the Dow slipping 12 points to 17,038 even as commodities prices advanced. Nasdaq rose 8 points to 4,817.

On the upside

Lumber Liquidators (NYSE: LL) settled with the Justice Department by paying a fine of $10 million.

Rising zinc prices lifted shares of Horsehead (Nasdaq: ZINC).

SolarWinds (NYSE: SWI) retained the services of J.P. Morgan and DLA Piper to review strategic alternatives.

On the downside

Super Micro Computer (Nasdaq: SMCI) cut its first quarter revenue guidance.
 
Ruby Tuesday (NYSE: RT) fell to a greater than expected loss for the first quarter.

The Department of Defense has temporarily prohibited Apollo Education Group's (Nasdaq: APOL) University of Phoenix from recruiting at military bases.
 
In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 lost 3 points to 2,009. Bitcoin added $1 to $243. 
The markets opened higher with the Dow rising 27 points to 17,078 as crude oil prices climbed. Nasdaq gained 19 points to 4,829.

On the upside

UTi Worldwide (Nasdaq: UTIW) will be acquired by DSV for a premium of approximately $1.35 billion.

Shares of Genie Energy (NYSE: GNE) continued rising.

Rising crude oil prices lifted shares of Energy XXI (Nasdaq: EXXI).

On the downside

LDR Holding (Nasdaq: LDRH) reported preliminary third quarter revenue that fell short of analyst expectations.
 
MKM Partners downgraded The Gap (NYSE: GPS) from a Buy rating to a Hold rating.

Shares of BioCryst Pharmaceuticals (Nasdaq: BCRX) extended its losses.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 held steady at 2,013. Bitcoin added $1 to $243.
The markets surged in late afternoon trading to close sharply higher with the Dow leaping 138 points to 17,050 as jobless claims dropped. Nasdaq gained 19 points to 4,810.

On the upside

Rising crude oil prices lifted shares of Penn West Petroleum (NYSE: PWE).

Genie Energy (NYSE: GNE) confirmed the existence of significant quantities of oil and gas in exploratory wells in Northern Israel.

Mistras Group (NYSE: MG) reported sharply higher first quarter earnings that beat expectations by a wide margin.

On the downside

Black Diamond (Nasdaq: BDE) sold its equity interest in POC for $65 million.
 
Harmonic (Nasdaq: HLIT) cut its third quarter revenue guidance.

Investors locked in profits on Cowen Group (Nasdaq: COWN).
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 17 points to 2,013. Bitcoin edged up a fraction to $242. 
The markets traded lower during the midday with the Dow falling 24 points to 16,888 even as first time applications for unemployment benefits dropped to its lowest level in 42 years. Nasdaq plunged 50 points to 4,740.

On the upside

Bloomberg wrote that Apollo Management may consider a bid for Tronox (NYSE: TROX).

Dell was reportedly engaged in discussions to acquire EMC (NYSE: EMC).

Elliott Management acquired a 6.6% stake in Polycom (Nasdaq: PLCM) and suggested a merger between Polycom and Mittel Networks (Nasdaq: MITL).

On the downside

Ocean Rig (Nasdaq: ORIG) said that oil market continued to be challenging and the company was considering disposing or scrapping some of its rigs.
 
The launch of Amazon's (Nasdaq: AMZN) Handmade at Amazon weighed down shares of eBay (Nasdaq: EBAY).

Investors locked in profits on Ambarella (Nasdaq: AMBA).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 slipped 3 points to 1,992. Bitcoin edged up a fraction to $243.
First time applications for unemployment benefits fell more than expected but the markets opened lower with the Dow losing 36 points to 16,875. Nasdaq dropped 35 points to 4,755.

On the upside

WaferGen Bio-systems (Nasdaq: WGBS) expects to report record revenue for the third quarter and lifted its full year revenue guidance.

Gannett (NYSE: GCI) will pay a premium of approximately $280 million to acquire Journal Media Group (NYSE: JMG).

Icahn Enterprises' tender offer of Vivus' (Nasdaq: VVUS) convertible senior notes expired.

On the downside

Cardiovascular Systems (Nasdaq: CSII) warned of wider losses for the first quarter.
 
The U.S. Preventive Services Task Force identified Exact Sciences (Nasdaq: EXAS) Cologuard as an alternative screening test for colorectal cancer rather than a recommended test.

BioCryst Pharmaceuticals (Nasdaq: BCRX) reported that its Phase 1 clinical trial of orally administered BCX7353 met its objectives and that it completed enrollment in OPuS-2 but the stock price fell.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while decliners edged out advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 6 points to 1,989. Bitcoin held steady at $242.
The markets closed higher with the Dow soaring 122 points to 16,912 even as crude oil prices slipped. Nasdaq climbed 42 points to 4,791.

On the upside

Evoke Pharma (Nasdaq: EVOK) amended its loan and security agreement with Square 1 Bank.

Bargain hunters lifted shares of Cross Country Healthcare (Nasdaq: CCRN).

Core-Mark Holding (Nasdaq: CORE) entered a five year strategic supply agreement with Murphy USA (NYSE: MUSA).

On the downside

Investors locked in profits on Denbury Resources (NYSE: DNR).
 
Cosi (Nasdaq: COSI) reported a drop in third quarter same store sales.

Platform Specialty Products (NYSE: PAH) lowered its full year earnings outlook.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 climbed 15 points to 1,995. Bitcoin held steady at $244.

Markets trade in positive territory

|
The markets retreated from early morning highs but continued trading in positive territory with the Dow climbing 65 points to 16,855. Nasdaq gained 22 points to 4,770.

On the upside

Shares of Pacific Biosciences (Nasdaq: PACB) extended its gains.

SunEdison (NYSE: SUNE) will eliminate 1,000 jobs and will no longer sell power plants to TerraForm Power or TerraForm Global.

MeetMe (Nasdaq: MEET) reported preliminary third quarter earnings and revenue above its previous guidance.

On the downside

Axion Power (Nasdaq: AXPW) was unable to reach an agreement with LCB International for funding and technology licensing.
 
Neonode (Nasdaq: NEON) forecast third quarter revenue below expectations and priced its public offering of 3.2 million common shares at the discounted price of $1.90 per share.

Cliffs Natural Resources (NYSE: CLF) terminated its pellet sale and purchase agreement with Essar Steel Algoma.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 gained 8 points to 1,988. Bitcoin held steady at $244.
Rising crude oil prices lifted the markets to a sharply higher open with the Dow soaring 148 points to 16,938. Nasdaq gained 29 points to 4,778.

On the upside

Teck Resources (NYSE: TCK) entered a long-term streaming agreement with Franco-Nevada.

Freeport-McMoRan (NYSE: FCX) entered an agreement with activist investor Carl Icahn.

ArcelorMIttal (NYSE: MT) reached an agreement with IMETAL to restructure the shareholding of the companies ArcelorMittal Algeria, ArcelorMittal Pipes and Tubes Algeria and ArcelorMittal Tebessa.

On the downside

Third quarter earnings and revenue for Yum Brands (NYSE: YUM) missed expectations and the company forecast full year earnings below estimates.
 
Nu Skin Enterprises (NYSE: NUS) cut its third quarter revenue guidance.

ContraVir Pharmaceuticals (Nasdaq: CTRV) priced its public offering of 5 million common shares at the discounted price of $3.00 per share.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 climbed 17 points to 1,997. Bitcoin held steady at $244.
It was a mixed close for the markets with the Dow rising 13 points to 16,790 as the trade deficit widened. Nasdaq tumbled 32 points to 4,748.

On the upside

More hedge funds are investing in Peabody Energy (NYSE: BTU) .

Rising crude oil prices lifted shares of Energy XXI (Nasdaq: EXXI) and Stone Energy (NYSE: SGY).

Shares of offshore drilling contractor Ocean Rig (Nasdaq: ORIG) climbed as crude oil prices rose.

On the downside

Nektar Therapeutics (Nasdaq: NKTR) closed a direct private placement of $250 million in senior secured notes.
 
Investors continued to lock in profits on Heron Therapeutics (Nasdaq: HRTX).

Sarepta Therapeutics (Nasdaq: SRPT) priced its secondary offering of 3.25 million common shares at the discounted price of $39 per share.
 
In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE while decliners edged out advancers by more than 5 to 4 on Nasdaq. The broader S&P 500 fell 7 points to 1,979. Bitcoin rose $5 to $244.
The markets traded mixed during the midday with the Dow rising 24 points to 16,801 after the International Monetary Fund cut its global economic outlook. Nasdaq dropped 43 points to 4,737.

On the upside

Unit (NYSE: UNT) increased its production growth guidance for 2015.

Freeport-McMoRan (NYSE: FCX) reduced the size of its board to nine members and will review strategic alternatives for its oil and gas business.

Rising crude oil prices lifted shares of Denbury Resources (NYSE: DNR).

On the downside

The Container Store (NYSE: TCS) disappointed with sharply lower second quarter earnings that fell short of expectations.
 
Profit taking weighed down shares of ContraVir Pharmaceuticals (Nasdaq: CTRV).

Investors locked in profits on Xenoport (Nasdaq: XNPT).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE while decliners edged out advancers by a margin of 7 to 5 on Nasdaq. The broader S&P 500 dropped 9 points to 1,977. Bitcoin gained $6 to $245.

Mixed open as trade deficit widens

|
The markets opened mixed with the Dow rising 21 points to 16,797 while Nasdaq fell 28 points to 4,753 as the nation's trade deficit widened in August.

On the upside

PMC-Sierra (Nasdaq: PMCS) will be acquired by Skyworks Solutions (Nasdaq: SWKS) for a premium of approximately $2 billion in cash.

WaferGen Bio-systems (Nasdaq: WGBS) launched its ICEL-L8(TM) Single Cell System at the American Society of Human Genetics meeting.

DuPont (NYSE: DD) chair and chief executive Ella Kullman announced her retirement.

On the downside

The U.S. Preventive Services Task Force included Exact Sciences' (Nasdaq: EXAS) Cologuard as an alternative screening test for colorectal cancer.
 
Ilumina (Nasdaq: ILMN) announced preliminary third quarter earnings that fell short of analyst expectations and forecast fourth quarter revenue below estimates prompting downgrades.

Radware (Nasdaq: RDWR) warned that third quarter revenue would fall short of previous guidance.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 lost 5 points to 1,982. Bitcoin rose $5 to $244. 
Optimism that interest rates will not increase in the near future sent the markets soaring to close sharply higher with the Dow zooming 304 points to 16,776. Nasdaq jumped 73 points to 4,781.

On the upside

Shares of California Resources (NYSE: CRC) and Energy XXI (Nasdaq: EXXI) climbed as crude oil prices rose.

Dow Chemical (NYSE: DOW) closed the transaction to separate its chlor-alkali and downstream derivatives business.

Shares of Micron Technology (Nasdaq: MU) extended its gains.

On the downside

The Bureau of Land Management determined that the Cadiz's (Nasdaq: CDZI) proposed use of a portion of the Arizona and California Railroad's 1875 Act right-of-way was outside the scope of the act.
 
Sequenom (Nasdaq: SQNM) entered a clinical collaboration with Seoul National University Hospital but the stock price fell.

Profit taking sank shares of Mallinckrodt (NYSE: MNK).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 jumped 35 points to 1,987. Bitcoin added $1 to $238.

Rate concerns recede, markets surge

|
The markets continued soaring during the midday with the Dow rocketing 259 points to 16,731 as an interest rate increase appeared less likely. Nasdaq leaped 62 points to 4,769.

On the upside

Willbros Group (NYSE: WG) will sell its Professional Services segment to TRC Companies (NYSE: TRR) for $130 million in cash.

Rising crude oil prices lifted shares of Denbury Resources (NYSE: DNR).

Shares of Navistar International (NYSE: NAV) continued climbing.

On the downside

Shares of Teladoc (NYSE: TDOC) extended its losses.
 
AtriCure (Nasdaq: ATRC) will acquire nContact in a cash and stock transaction.

Investors locked in profits on Endo International (Nasdaq: ENDP).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 1 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 leaped 31 points to 1,983. Bitcoin edged up to $238. 
Indications that the Federal Reserve will not raise interest rates sent the markets soaring to a sharply higher open with the Dow jumping 185 points to 16,658. Nasdaq surged 49 points to 4,756.

On the upside

ContraVir Pharmaceuticals (Nasdaq: CTRV) reported preliminary positive data for its CMX157 to treat hepatitis B.

Bargain hunters continued to snap up shares of Amicus Therapeutics (Nasdaq: FOLD).

Spark Therapeutics (Nasdaq: ONCE) reported upbeat data from a Phase 3 trial of SPK-RPE65.

On the downside

Citron tweeted that Valeant Pharmaceuticals (NYSE: VRX) was a lemon.
 
Piper Jaffray downgraded FireEye (Nasdaq: FEYE) from an Overweight rating to a Neutral rating.

The Brazilian regulatory agency ANVISA temporarily suspended activity at a contract manufacturer for Sientra (Nasdaq: SIEN).
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 8 to 1 on the NYSE and by more than 5 to 1 on Nasdaq. The broader S&P 500 leaped 24 points to 1,975. Bitcoin edged up a fraction to $237.
The markets surged in late afternoon trading to close sharply higher with the Dow leaping 200 points to 16,472 as disappointing economic data sparked optimism for interest rates to remain at record low levels. Nasdaq jumped 80 points to 4,707.

On the upside

Rising crude oil prices lifted shares of Petrobras (NYSE: PBR).

Pfizer (NYSE: PFE) completed its exchange offering.

Efforts by the Chinese government to provide additional targeted stimulus measures lifted shares of Alibaba (NYSE: BABA).

Shares of Freeport-McMoRan (NYSE: FCX) rose as copper prices climbed.
 
On the downside

Shares of Capital Southwest (Nasdaq: CSWC) fell after completing the spinoff of  CSW Industries yesterday.

Investors locked in profits on XOMA (Nasdaq: XOMA).
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 soared 27 points to 1,951. Bitcoin eased a fraction to $235. 
The markets recovered early morning losses to trade mixed during the midday with the Dow slipping 3 points to 16,268 over expectations that weak economic data will delay an interest rate increase. Nasdaq rose 9 points to 4,636.

On the upside

CalAmp (Nasdaq: CAMP) reported higher second quarter earnings and revenue that topped analyst estimates.

Fourth quarter earnings and revenue for Micron Technology (Nasdaq: MU) surpassed expectations.

Bargain hunters lifted shares of Twitter (Nasdaq: TWTR).
 
On the downside

Oppenheimer downgraded Horsehead (Nasdaq: ZINC) from an Outperform rating to a Perform rating.

Third quarter revenue for Progress Software (Nasdaq: PRGS) fell short of expectations.
 
Morgan Stanley downgraded Diplomat Pharmacy (NYSE: DPLO) from an Overweight rating to an Equal Weight rating.

In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The broader S&P 500 held steady at 1,923 Bitcoin held steady at $236. 
Disappointing jobs data sent the markets tumbling to a sharply lower open with the Dow plunging 217 points to 16,054. Nasdaq plummeted 63 points to 4,563.

On the upside

XenoPort (Nasdaq: XNPT) will discontinue development of XP23829 in order to maximize the value of HORIZANT Extended Release Tablets. The company also appointed Vincent J. Angotti to the position of chief executive officer.

The Wall Street Journal reported that Sprint (NYSE: S) will eliminate jobs and cut up to $2.5 billion in expenses over the next six months.

The Chinese government committed to supporting Macau's economy sending shares of Wynn Resorts (Nasdaq: WYNN) higher.
 
On the downside

Amicus Therapeutics (Nasdaq: FOLD) received additional regulatory guidance from the Food and Drug Administration for migalastat monotherapy to treat Fabry disease and will no longer be able to submit a New Drug Application at the end of the year.

A shareholder class action lawsuit against Bank of America (NYSE: BAC) for its role in the $690 million sale of Zale will move forward.
 
Wedbush Securities initiated coverage of Facebook (Nasdaq: FB) with an Outperform rating and a $115 price target but the stock price fell.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 plummeted 26 points to 1,896. Bitcoin held steady at $236.

Flat close on economic data

|
The markets closed flat with the Dow slipping 12 points to 16,272 as manufacturing activity expanded at a slower pace. Nasdaq rose 6 points to 4,627.

On the upside

Bargain hunters continued to snap up shares of Sequenom (Nasdaq: SQNM).

The New Jersey Division of Gaming Entertainment authorized Amaya (Nasdaq: AYA) to operate PokerStars and Full Tilt in New Jersey.

Bargain hunters lifted shares of OvaScience (Nasdaq: OVAS).
 
On the downside

Capital Southwest (Nasdaq: CSWC) completed the spinoff of CSW Industrials (Nasdaq: CSWI).

Shares of Kindred Healthcare (NYSE: KND) continued falling.
 
Bloomberg reported that Brazil's Lower House approved costly retirement benefits sending shares of Petrobras (NYSE: PBR) lower.

In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while decliners outpaced advancers by 7 to 5 on Nasdaq. The broader S&P 500 rose 3 points to 1,923. Bitcoin added $1 to $237.
The markets extended its losses during the midday with the Dow plunging 135 points to 16,149 as China's factory output contracted and euro zone manufacturing growth weakened. Nasdaq tumbled 33 points to 4,587.

On the upside

Shares of XPO Logistics (NYSE: XPO) continued rising.

Rising crude oil prices lifted shares of Oasis Petroleum (NYSE: OAS).

Peabody Energy (NYSE: BTU) completed its 1-for-15 reverse stock split.
 
On the downside

DigiTime wrote that Apple (Nasdaq: AAPL) iPhone suppliers expects lower shipments for the fourth quarter.

Profit taking weighed down shares of Alcoa (NYSE: AA).
 
Shares of Twitter (NYSE: TWTR) fell ahead of the expected appointment of cofounder Jack Dorsey to the position of chief executive officer.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 fell 8 points to 1,911. Bitcoin added $1 to $237.

Lower open as jobless claims rise

|
An increase in first time applications for unemployment benefits weighed the markets down to a lower open with the Dow falling 55 points to 16,229. Nasdaq dropped 23 points to 4,596.

On the upside

Sarepta Therapeutics (Nasdaq: SRPT) reported additional positive data from a Phase IIb study of its Duchenne muscular dystrophy drug eteplirsen.

Pacific Biosciences of California (Nasdaq: PACB) launched a new nucleic acid sequencing platform.

PBF Energy (NYSE: PBF) will acquire Exxon Mobil's (NYSE: XOM) in Torrance for approximately $537.5 million.
 
On the downside

Dunkin' Brands Group (Nasdaq: DNKN) forecast third revenue below analyst expectations and announced plans to close 100 stores.

Crocs (Nasdaq: CROX) cut its third quarter sales guidance.
 
Illumina (Nasdaq: ILMN) launched the BaseSpace Professional and Enterprise Editions of its Laboratory Information Management Systems solutions but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 slipped 3 points to 1,916. Bitcoin held steady at $235.

About this Archive

This page is an archive of entries from October 2015 listed from newest to oldest.

September 2015 is the previous archive.

November 2015 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12